Hims & Hers Health (HIMS) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
1 Feb, 2026Opening remarks and agenda
CEO welcomed stockholders, directors, officers, employees, auditors, and counsel to the virtual meeting and outlined the agenda, including formal matters, voting, and a Q&A session.
Notice of the meeting, proxy statement, and proxy card were mailed to all stockholders of record, and proof of notice was filed with the meeting minutes.
Corporate governance
Quorum was confirmed, allowing the meeting to transact business.
Voting rights were clarified: Class A shares have 1 vote each, Class V shares have 175 votes each.
Voting was conducted by proxy ballot, with options to vote or change votes during the meeting.
Board and executive committee updates
Eight directors were nominated and elected for a one-year term: Andrew Dudum, Dr. Patrick Carroll, Dr. Delos Cosgrove, Anja Manuel, Christopher Payne, Christiane Pendarvis, Andrea Perez, and David Wells.
Latest events from Hims & Hers Health
- Proxy covers director elections, auditor ratification, and executive pay, highlighting strong growth and governance.HIMS
Proxy filing28 Apr 2026 - Votes sought for nine directors, auditor ratification, and executive pay at June 2026 meeting.HIMS
Proxy filing28 Apr 2026 - Personalized care, tech-driven growth, and global expansion fuel strong revenue and margin outlook.HIMS
Morgan Stanley Technology, Media & Telecom Conference 20262 Mar 2026 - 2025 revenue up 59% to $2.35B, with strong subscriber and specialty growth, and robust 2026 outlook.HIMS
Q4 202524 Feb 2026 - Q2 revenue up 52% to $315.6M, net income $13.3M, strong subscriber and margin growth.HIMS
Q2 20242 Feb 2026 - Personalized, tech-driven healthcare and GLP-1s fuel rapid growth and operational gains.HIMS
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Q3 2024 revenue up 77% to $401.6M, net income $75.6M, and 2M subscribers.HIMS
Q3 202417 Jan 2026 - 2024 revenue up 69% to $1.5B, net income $126M, 2025 guidance set at $2.3–$2.4B revenue.HIMS
Q4 20247 Jan 2026 - Q1 revenue up 111% to $586M, with strong subscriber growth and raised full-year guidance.HIMS
Q1 202520 Dec 2025